Fatty Acids, Nonesterified

apolipoprotein B ; Homo sapiens

13 Article(s)
Pub. Year
#Total Relationships
1 29659358 [Role of the enterocyte in type 2 diabetes mellitus associated dyslipidemia]. 2018 1
2 18333368 Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for metabolic syndrome, hepatic steatosis and steatohepatitis. 2007 1
3 16239593 Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein. 2006 Jan 1
4 14871427 A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis. 2004 Mar 1
5 11755941 Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. 2002 Jan 1
6 9555856 Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries. 1998 Apr 1
7 7657029 Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. 1995 Sep 1
8 7677772 Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. 1995 Sep 14 1
9 8343493 Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern. 1993 Aug 1
10 8487662 Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus. 1993 Apr 1
11 1332692 Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. 1992 Nov 15 3
12 2665826 [Effect of lipopolysaccharide toxin on lipid and protein composition of human serum low density lipoproteins]. 1989 Mar 1
13 3042202 HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. 1988 1